We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
10401
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$55K ﹤0.01%
+7,883
New +$41.1K
ORTX
10402
PUT
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$55K ﹤0.01%
1,270
-1,240
-49% -$55.5K
LEJU
10403
CALL
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$55K ﹤0.01%
+2,380
New +$56K
ADMS
10404
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
$55K ﹤0.01%
+12,800
New +$54.8K
BBDO icon
10405
Banco Bradesco
BBDO
$35.7B
$54K ﹤0.01%
+14,101
New +$46K
CHNR icon
10406
China Natural Resources
CHNR
$4.64M
$54K ﹤0.01%
+978
New +$52.7K
SIFY
10407
Sify Technologies
SIFY
$1.11B
$54K ﹤0.01%
7,035
+1,891
+37% +$12.7K
CPSS icon
10408
PUT
Consumer Portfolio Services
CPSS
$208M
$53K ﹤0.01%
+12,500
New +$50.4K
DHC
10409
Diversified Healthcare Trust
DHC
$2.13B
$53K ﹤0.01%
12,694
-35,776
-74% -$141K
LFT
10410
Lument Finance Trust
LFT
$35.9M
$53K ﹤0.01%
16,280
-3,528
-18% -$10.3K
QUAD icon
10411
CALL
Quad
QUAD
$559M
$53K ﹤0.01%
+13,900
New +$42.7K
SYBX
10412
CALL
DELISTED
Synlogic
SYBX
$53K ﹤0.01%
+1,633
New +$52.2K
UXIN
10413
CALL
Uxin Ltd
UXIN
$295M
$53K ﹤0.01%
607
+167
+38% +$18.6K
XTIA icon
10414
XTI Aerospace
XTIA
$57.3M
0
SECO
10415
PUT
DELISTED
Secoo Holding Limited ADR
SECO
$53K ﹤0.01%
+2,300
New +$62K
PHAS
10416
CALL
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$53K ﹤0.01%
15,700
-1,200
-7% -$4.3K
GPL
10417
CALL
DELISTED
Great Panther Mining Limited
GPL
$53K ﹤0.01%
6,270
-170
-3% -$1.43K
LSTA icon
10418
PUT
Lisata Therapeutics
LSTA
$9.47M
$52K ﹤0.01%
2,427
-1,940
-44% -$46K
APTX
10419
CALL
DELISTED
Aptinyx Inc. Common Stock
APTX
$52K ﹤0.01%
+14,900
New +$51.9K
NH
10420
DELISTED
NantHealth, Inc
NH
$52K ﹤0.01%
+1,077
New +$40.5K
AFI
10421
DELISTED
Armstrong Flooring, Inc.
AFI
$52K ﹤0.01%
13,602
-10,662
-44% -$38.2K
ACR
10422
ACRES Commercial Realty
ACR
$112M
$51K ﹤0.01%
+4,232
New +$37.9K
CLPS icon
10423
CLPS Inc
CLPS
$26.9M
$51K ﹤0.01%
+16,656
New +$51.7K
CRVS icon
10424
PUT
Corvus Pharmaceuticals
CRVS
$1.12B
$51K ﹤0.01%
+14,400
New +$58K
JILL icon
10425
J. Jill
JILL
$277M
$51K ﹤0.01%
+13,706
New +$53.2K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.